Geode Capital Management, LLC Aravive, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.11 - $0.22 $11,332 - $22,665	103,024 Added 34.23%	403,975 $48,000
Q3 2023 Nov 13, 2023	SELL	$0.11 - $1.76 $341 - $5,470	-3,108 Reduced 1.02%	300,951 $39,000
Q2 2023 Aug 11, 2023	BUY	$1.25 - $1.92 $111,051 - $170,574	88,841 Added 41.28%	304,059 $383,000
Q1 2023 May 15, 2023	BUY	$1.29 - $2.46 $93,435 - $178,180	72,431 Added 50.73%	215,218 $430,000
Q4 2022 Feb 13, 2023	BUY	$1.2 - $1.83 $7,485 - $11,415	6,238 Added 4.57%	142,787 $188,000
Q2 2022 Aug 12, 2022	BUY	$0.93 - $1.9 $6,910 - $14,118	7,431 Added 5.76%	136,549 $134,000
Q1 2022 May 13, 2022	SELL	$1.85 - $2.75 $3 - $5	-2 Reduced -0.0%	129,118 $249,000
Q3 2021 Nov 12, 2021	BUY	$3.67 - $5.8 $8,914 - $14,088	2,429 Added 1.92%	129,120 $480,000
Q2 2021 Aug 13, 2021	SELL	$4.65 - $6.42 $288,444 - $398,239	-62,031 Reduced 32.87%	126,691 $757,000
Q1 2021 May 12, 2021	BUY	$5.11 - $9.24 $6,014 - $10,875	1,177 Added 0.63%	188,722 $1.24 Million
Q4 2020 Feb 12, 2021	BUY	$4.36 - $6.51 $82,312 - $122,902	18,879 Added 11.19%	187,545 $1.06 Million
Q3 2020 Nov 13, 2020	BUY	$4.7 - $12.06 $19,556 - $50,181	4,161 Added 2.53%	168,666 $792,000
Q2 2020 Aug 13, 2020	BUY	$5.18 - $14.81 $400,605 - $1.15 Million	77,337 Added 88.72%	164,505 $1.91 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $13.77 $68,785 - $270,621	19,653 Added 29.11%	87,168 $502,000
Q4 2019 Feb 13, 2020	BUY	$6.21 - $14.02 $231,993 - $523,759	37,358 Added 123.88%	67,515 $922,000
Q3 2019 Nov 12, 2019	SELL	$5.2 - $8.68 $748 - $1,249	-144 Reduced 0.48%	30,157 $226,000
Q2 2019 Aug 14, 2019	BUY	$5.65 - $7.5 $406 - $540	72 Added 0.24%	30,301 $181,000
Q1 2019 May 14, 2019	BUY	$3.35 - $8.27 $904 - $2,232	270 Added 0.9%	30,229 $212,000
Q4 2018 Feb 13, 2019	BUY	$3.23 - $8.7 $96,767 - $260,643	29,959 New	29,959 $105,000

Others Institutions Holding ARAV

# of Institutions

Shares Held

28.1K

Call Options Held

Put Options Held

View Full List

About Aravive, Inc.

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

More about ARAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account